Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Additive glucose-lowering effects of glucagon-like peptide- 1 and metformin type 2 diabetes. / Zander, M.; Taskiran, M.; Toft-Nielsen, M.B.; Holst, J.J.

    In: Diabetes Care, No. 24, 2001, p. 720-725.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Antidiabetogenic action of glucagon-like peptide- 1 related to administration relative to meal intake in subjects with type 2 diabetes. / Gutniak, M.K.; Svartberg, J.; Hellstrom, P.M.; Holst, J.J.

    In: J Intern Med, No. 250, 2001, p. 81-87.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Assesment of hepatic insulin action in obese type 2 diabetic patients. / Staehr, P.; Hother-Nielsen, Ole; Levin, K.; Holst, J.J.

    In: Diabetes, No. 50, 2001, p. 1363-1370.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Attenuated processing of proglucagon and glucagon-like peptide- 1 in carboxypeptidase E-deficient mice. / Friis-Hansen, L.; Lacourse, K.A.; Samuelson, L.C.; Holst, J.J.

    In: J. Endocrinol., No. 169, 2001, p. 595-602.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Determinants of the effectiveness of glucagon-like peptide- 1 in type 2 diabetes. / Toft-Nielsen, M.B.; Madsbad, S.; Holst, J.J.

    In: J Clin Endocr Metab, No. 86, 2001, p. 3853-3860.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. / Toft-Nielsen, M B; Damholt, M B; Madsbad, Sten; Hilsted, L M; Hughes, T E; Michelsen, B K; Holst, Jens Juul.

    In: Journal of Clinical Endocrinology and Metabolism, Vol. 86, No. 8, 2001, p. 3717-3723.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs. / Deacon, C.F.; Danielsen, P.; Klarskov, L.; Holst, J.J.; Olesen, M.

    In: Diabetes, No. 50, 2001, p. 1588-1597.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Diurnal metabolic profiles after 14 d of an ad libitum high-starch, high-sucrose, or high-fat diet in normal-weight never-obese and postobese women. / Raben, A.; Holst, Jens Juul; Madsen, J.; Astrup, A.

    In: American Journal of Clinical Nutrition, Vol. 73, 2001, p. 177-89.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Effect of calcitonin gene-related peptide (CGRP) on motility and on the release of substance P, neurokinin A, somatostatin and gastrin in the isolated perfused porcine antrum. / Rasmussen, T N; Schmidt, P; Poulsen, S S; Holst, J J; Poulsen, Steen Seier.

    In: Neurogastroenterology and Motility, Vol. 13, No. 4, 01.08.2001, p. 353-359.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Effect of glucagon-like peptide- 1 (7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. / Vella, A.; Shah, P.; Basu, R.; Holst, J.J.

    In: Diabetes, No. 50, 2001, p. 565-572.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 Next

ID: 4207